Orthocell Limited (OCC.AX)

0.3750 -0.0150 (-3.85%) At close: 03:48PM AEST

Orthocell Limited

Building 191
Murdoch University 90 South Street
Murdoch, WA 6150
Australia
61 8 9360 2888
https://orthocell.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Paul Frederick Anderson	CEO, MD & Executive Director	650.97k	N/A	1966
Ms. Nicole Jane Telford	Chief Financial Officer	N/A	N/A	N/A
Mr. Alex McHenry	Chief Operating Officer	N/A	N/A	N/A
Prof. Ming Hao Zheng	Chief Scientific Officer and Member of Medical & Scientific Advisory Board	N/A	N/A	N/A
Mr. Tony Macintyre	Chief Technical Operations Officer	N/A	N/A	N/A
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.	Company Secretary	N/A	N/A	1963

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.

Corporate governance

Orthocell Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.